TICAD8 Official Side Event
Health-Related Quality of Life and Well-being by Drug Development and African Traditional Medicines
Health-Related Quality of Life and Well-being by Drug Development and African Traditional Medicines
September 20, 2022
From 16:00 - 18:00 (Japanese time)
International ONLINE Symposium in English and Japanese (with simultaneous translation)
Dear All
Thank you very much for participating and watching this event. We also apologize for the delay in announcement. In addition to corrections and adjustments to the recording, we have also added subtitles to the audio for those portions of the symposium that had audio problems, so that you can easily understand the content of the symposium.
Thank you very much for your cooperation.
皆様へ
本イベントにご参加およびご視聴いただき、誠にありがとうございました。また、ご連絡が遅くなり申し訳ございませんでした。録画ファイルの修正・調整に加え、音声に不具合がある箇所についても、シンポジウムの内容をご理解いただきやすいようよう、字幕を付記しました。
どうぞよろしくお願いいたします。
Chers tous
Merci beaucoup d'avoir participé et regardé cet événement. Nous nous excusons également pour le retard de l'annonce. En plus des corrections et ajustements apportés à l'enregistrement, nous avons également ajouté des sous-titres à l'audio pour les parties du symposium qui avaient des problèmes d'audio, afin que vous puissiez facilement comprendre le contenu du symposium.
Merci beaucoup pour votre coopération.
Kumamoto University is collaborating with African universities to conduct research for the improvement of healthcare services in Africa by utilizing more effectively and safely the medicinal plants that have been traditionally used. Our research endeavors are based on cutting-edge science and knowledge to promote healthier and better lives in Africa, and to improve its healthcare services. As one of these activities, we held the 7th Tokyo International Conference for African Development (TICAD7) Post Forum in Kumamoto. Based on the discussions on healthcare and medical environment at the TICAD7, we announced the "Kumamoto statement 2019" as a proposal for improving healthcare in Africa, and have been working in accordance with this statement through Public-Private-Partnerships (P3) including academia (PPP-A).
Since the end of 2019, the global pandemic caused by the SARS-CoV-2 virus has dramatically transformed the global medical and public health environment. Particularly in Africa, where viral infections were still the leading cause of death, socioeconomic activities have significantly stagnated due to weak social infrastructure against viral infections. Especially, vulnerable populations have been severely affected. In the future, the provision for adequate healthcare in Africa, including for COVID-19, will be crucial to promote a healthier and better life.
In order to contribute to the improvement of healthcare services that are compatible with the current standard of living and healthcare systems in Africa, it is important to utilize not only state-of-the-art medicine but also the traditional medicines that are being used by 80% of the African population. Therefore, we decided to hold an international online symposium "Health-Related Quality of Life and Well-being by Drug Development and African Traditional Medicines," on September 20th 2022, as an official side event of TICAD8.
|
---|
|
Review Kumamoto Statement 2019yr version |
---|---|
|
|
Comments from experts |
---|---|
|
President, Kumamoto University
President, Association of African Economy and Development
hairman of the executive committee of Previous symposium
Vice President, Kumamoto University
Eisai Co. Ltd., Director, Representative Corporate Officer and CEO
Dr. Naito received an MBA from Northwestern University Kellogg School of Management in June 1974. He joined Eisai Co., Ltd. in October 1975 and has been President and CEO since April 1988. He was Vice President of the Japan Pharmaceutical Manufacturers Association (JPMA) from May 1998 to May 2019, President of the International Pharmaceutical Manufacturers Associations (IFPMA) from November 2009 to November 2010, President of the Federation of Pharmaceutical Manufactures’ Associations of Japan (FPMAJ) and Chair of Dolder Group from May 2012 to May 2014, President of the Pharmaceutical Manufacturers’ Association of Tokyo and Vice President of the Federation of Pharmaceutical Manufactures Associations of Japan (FPMAJ) from June 2016 to June 2018, respectively.
He was conferred an honorary doctorate of science from UCL (University College of London) in July 2013. He was awarded an honorary CBE in April 1999 and KBE in April 2014 from the United Kingdom.
Muhimbili Univ. of Health And Allied Sciences, Tanzania
He is also a Visiting Associate Professor of Kumamoto University in Japan. He has over ten-year experience in Public Health Nutrition, Nutrition and Food Security, Adolescent, Maternal and Child Health Research, Health Systems Research, and HIV/AIDS research. He has worked and led teams to develop national guidelines on various aspects including STIs, HIV/AIDS and TB; Nutrition; and Reproductive and Child Health for Tanzania mainland and Zanzibar. He has conducted a number of researches in nutrition and other public health fields and disseminated his research work widely in more than 65 peer reviewed research articles, 3 book chapters, and international conferences in Africa, Asia, and Australia.
Before joining MUHAS, Dr. Sunguya worked Muhimbili National Hospital as a clinician, and with the Department of Nutrition for Health and Development, in WHO HQ Geneva as an intern. Currently, he is also serving as an Associate Editor for the American Journal of Clinical Nutrition: Tanzania Medical Journal, and BMC nutrition journal. He is also a HIV implementation science fellow at MUHAS and Harvard T.H. Chan School of Public Health program; a senior research mentor for THET program; a core member of the Tanzania Immunization Technical Advisory Committee; a core member of the National committee on Adverse Events Following Immunization; a member of National Measles Certification committee; a member of the WHO Nutrition Guidance Expert Advisory Group-Subgroup on Diet and Health. He chairs the MUHAS Research and Ethics Committee and is a contact person for research collaborations and grants for the institution.
KEMRI, Kenya
Festus M Tolo is a Phyto-Medical Biologist with a PhD in Medicinal Phytochemistry. He is the Chief Research Officer and the Head of NAPREDA-KEMRI and Fellow at the African Scientific Institute.
He is an awardee of the the Nelon Gold Award (NGA) of KEMRI and a recipient of the Inter-Academy Medical Panel (IAMP) Distinguished Scientist Award in Natural Products Research by the China Academy of Chinese Medical Sciences (CACMS) and Chinese Academy of Engineering (CAE). He is a part time Lecturer in Medical Microbiology and peer Reviewer of Quality Standards (QS) for the Commission for University Education (CUE), Kenya.
Kumamoto Univ., Japan
Kumamoto Univ., Japan
Toyota Tsusho Co.
Assistant General Manager, International Cooperation Group, Automotive Planning Department, Automotive Division, Toyota Tsusho Corporation.
Career, Specialty, etc.
Experienced in the pharmaceutical and automobile divisions of a trading company, specializing in pharmaceuticals, medical equipment and vehicles.
He specializes in international aid for pharmaceuticals, medical equipment, and vehicles, and in sales to the United Nations.
President, NGO Rocinantes
Member of the House of Representatives
Elected to the House of Representatives 11 times (12 times in total) until the October 2021 election.